Published in
American Society of Hematology, Blood, 15(130), p. 1772-1774
DOI: 10.1182/blood-2017-07-795302
Links
Tools
Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma
Journal article published in 2017 by
Antonio Salar 
,
Eva Domingo-Domenech,
Carlos Panizo ,
Concepción Nicolás,
Joan Bargay,
Ana Muntañola,
Miguel Canales,
José Luis Bello,
Juan Manuel Sancho,
José Francisco Tomás,
María José Rodríguez,
Javier Peñalver,
Carlos Grande,
José Javier Sánchez-Blanco,
Luis Palomera
and other authors.
,
Eva Domingo-Domenech,
Carlos Panizo ,
Concepción Nicolás,
Joan Bargay,
Ana Muntañola,
Miguel Canales,
José Luis Bello,
Juan Manuel Sancho,
José Francisco Tomás,
María José Rodríguez,
Javier Peñalver,
Carlos Grande,
José Javier Sánchez-Blanco,
Luis Palomera
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 